Cited 71 times in
Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김응권 | - |
dc.contributor.author | 김태임 | - |
dc.date.accessioned | 2015-05-19T17:06:15Z | - |
dc.date.available | 2015-05-19T17:06:15Z | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 0277-3740 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/107512 | - |
dc.description.abstract | PURPOSE: To evaluate the effect of subconjunctival bevacizumab (Avastin) administration on corneal neovascularization (NV) in rabbits. METHODS: NV was induced by placing a suture at the corneal periphery of the right eye of 20 rabbits. Immediately after suturing and again 1 week later, rabbits were divided into 2 groups and administered a subconjunctival injection of normal saline (control) or bevacizumab (Avastin; 5 mg/0.2 mL), respectively. On day 14, digital photographs of the cornea were taken and analyzed to determine the area of the cornea covered by NV. In addition, immunohistochemical analysis was used to determine CD31 and vascular endothelial growth factor (VEGF) expression in corneal tissue. RESULTS: Analysis of digital photographs showed that there was less corneal NV in bevacizumab-treated eyes than in controls (P < 0.001, Mann-Whitney U test). In addition, there was less staining for VEGF and CD31 in corneas from bevacizumab-treated eyes than in control eyes. Subconjunctival bevacizumab injections were not associated with any complications during observation. CONCLUSIONS: Subconjunctival bevacizumab administration decreased suture-induced corneal neovascularization in rabbits | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 349~352 | - |
dc.relation.isPartOf | CORNEA | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Angiogenesis Inhibitors/administration & dosage* | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Antibodies, Monoclonal/administration & dosage* | - |
dc.subject.MESH | Antibodies, Monoclonal, Humanized | - |
dc.subject.MESH | Bevacizumab | - |
dc.subject.MESH | Conjunctiva | - |
dc.subject.MESH | Corneal Neovascularization/drug therapy* | - |
dc.subject.MESH | Corneal Neovascularization/metabolism | - |
dc.subject.MESH | Corneal Neovascularization/pathology | - |
dc.subject.MESH | Disease Models, Animal* | - |
dc.subject.MESH | Fluorescent Antibody Technique, Indirect | - |
dc.subject.MESH | Injections | - |
dc.subject.MESH | Platelet Endothelial Cell Adhesion Molecule-1/metabolism | - |
dc.subject.MESH | Rabbits | - |
dc.subject.MESH | Vascular Endothelial Growth Factor A/metabolism | - |
dc.title | Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin). | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Ophthalmology (안과학) | - |
dc.contributor.googleauthor | Tae-im Kim | - |
dc.contributor.googleauthor | Sang Woo Kim | - |
dc.contributor.googleauthor | Sunwoong Kim | - |
dc.contributor.googleauthor | Terry Kim | - |
dc.contributor.googleauthor | Eung Kweon Kim | - |
dc.identifier.doi | 10.1097/ICO.0b013e31815cf67d | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00831 | - |
dc.contributor.localId | A01080 | - |
dc.relation.journalcode | J00648 | - |
dc.identifier.eissn | 1536-4798 | - |
dc.identifier.pmid | 18362666 | - |
dc.identifier.url | http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00003226-200804000-00019&LSLINK=80&D=ovft | - |
dc.subject.keyword | cornea | - |
dc.subject.keyword | neovascularization | - |
dc.subject.keyword | bevacizumab | - |
dc.contributor.alternativeName | Kim, Eung Kweon | - |
dc.contributor.alternativeName | Kim, Tae Im | - |
dc.contributor.affiliatedAuthor | Kim, Eung Kweon | - |
dc.contributor.affiliatedAuthor | Kim, Tae Im | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 27 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 349 | - |
dc.citation.endPage | 352 | - |
dc.identifier.bibliographicCitation | CORNEA, Vol.27(3) : 349-352, 2008 | - |
dc.identifier.rimsid | 57256 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.